Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 17, 2026
Multidisciplinary assessment of patients with extensive stage small cell lung cancer: A geriatric tumor board.
Journal: CA: a cancer journal for clinicians
Published: March 14, 2025
Erratum: Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights.
Journal: JCO oncology practice
Published: February 20, 2025
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 20, 2024
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights.
Journal: JCO oncology practice
Published: November 20, 2024
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 11, 2023
Assessment of Frailty and Risk of Chemotherapy Toxicity at a Geriatric-Oncology Multidisciplinary Clinic.
Journal: Rhode Island medical journal (2013)
Published: April 25, 2023
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors.
Journal: American journal of clinical oncology
Published: March 24, 2023
Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab.
Journal: Advances in radiation oncology
Published: September 02, 2022
Functional Status and Survival in Older Nursing Home Residents With Advanced Non-Small-Cell Lung Cancer: A SEER-Medicare Analysis.
Journal: JCO oncology practice
Published: February 07, 2022
TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations.
Journal: Lung Cancer (Auckland, N.Z.)
Published: April 16, 2019
Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions .
Journal: Clinical journal of oncology nursing
Published: January 20, 2018
Last Updated: 09/26/2026